首页 产业/市场分类 出版商一览 Email 通知 GII媒体代理会议 公司简介 联络我们
- English Japanese Korean
首页 > 市场调查报告书 > 制药 > 骨头疾病治疗 > 筋骨格疾病治疗药的合夥交易·合作动向
产业/市场分类
制药 (4411)
肥胖症治疗 (48)
非专利药 (116)
疫苗 (166)
神经疾病 (173)
骨头疾病治疗 (39)
动物用医药 (17)
处方药 (89)
规章 (104)
感染疾病 (311)
精神病 (78)
制药企业 (489)
糖尿病 (157)
癌症 (832)
药物开发 (1251)
DDS (173)
OTC 非处方药 (146)
市场调查报告书

筋骨格疾病治疗药的合夥交易·合作动向

Partneringdesk Deals and alliances in musculoskeletal diseases

出版商 Pharmalicensing Ltd.
出版日期 2006年04月 商品编码 38284
内容信息 英文 382 pages
价格
US $ 2495 PDF by E-mail (Single User License)


筋骨格疾病治疗药的合夥交易·合作动向 是由出版商Pharmalicensing Ltd.在2006年04月所出版的。 这份英文市场调查报告书包含382 pages 价格从美金2495起跳。

简介

在全球保健领域之产品策略与事业拓展谘询上,经验丰富的英国市调公司 Pharmalicensing (总公司:约克州),详尽地调查与分析筋骨格疾病治疗药的合夥交易·合作动向,并出版综合报告书 "Partneringdesk Deals and alliances in musculoskeletal diseases"

此报告书在下面的内容里,不仅说明2001年1月至2006年3月筋骨格疾病治疗药370件合夥交易及合作动向,也探讨现今活动中的合夥动向、竞争分析及基准、主要25家企业的档案等。

说明

第1章 各企业的交易概要

第2章 各开发阶段的交易概要

第3章 交易种类

  • 各交易业务数据

第4章 产业领域

  • 各产业领域的交易概要
  • 9种产业领域的选择

第5章 主要25家企业的档案

  • 过去5年内治疗领域的主要企业档案
  • 企业概要
  • 产业策略
  • 合夥策略
  • 研究开发
  • 历史
    • Aastrom Biosciences
    • BioXell SpA
    • Celltech
    • ChondroGene Limited
    • 中外制药股份有限公司
    • dj Orthopedics Inc
    • Galapagos Genomics nv
    • GlaxoSmithKline
    • Hologic Inc
    • Incyte
    • Inion
    • Musculoskeletal Transplant Foundation
    • Novartis AG
    • Orthofix International NV
    • Orthovita
    • Pfizer Inc
    • Proskelia Pharmaceuticals
    • Quidel Corporation
    • Roche
    • Smith & Nephew
    • Stryker
    • Sunlight Medical Ltd
    • Unigene Laboratories Inc
    • Wyeth
    • Zimmer Holdings

第6章 交易、合作的详细情报

  • 2001年1月至2006年3月的交易概要
  • 财务情报

用语

  • 图1:2001年至2005年的交易
  • 图2:2005年的交易
  • 图3:每年的筋骨格疾病治疗药交易
  • 图4:各开发阶段(初期)筋骨格疾病治疗药的交易
  • 图5:各开发阶段(中期)筋骨格疾病治疗药的交易
  • 图6:各开发阶段(后期)筋骨格疾病治疗药的交易
  • 图7:各类筋骨格疾病治疗药的交易
  • 图8:各产业领域的筋骨格疾病治疗药交易

目录

Abstract

Partneringdesk Deals and alliances in musculoskeletal diseases

Partneringdesk deals and alliances in musculoskeletal diseases provides an in-depth view of 370 deals and alliances announced in musculoskeletal diseases between 2001 and 2006, in a clear and accessible PDF format.

Introduction

A diagrammatical and analytical summary of the deals and dealmakers in the therapy area over a five-year period.

Chapter 1: Deals by company

A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.

Chapter 2: Deals by development stage

A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.

Chapter 3: Deal type

Access deal information by type of transaction - see who is licensing or partnering and using what type of deal.

Chapter 4: Industry sector

Deal announcements sorted by industry sector. Choose from nine sectors.

Chapter 5: Top 25 company profiles

Summary profiles for the most active companies in the therapy area over the past five years, including contact details, business strategy, partnering strategy, R&D and history.

Chapter 6: Detailed listing of deals and alliances

A full index of all the deals announced between Jan 2001 and Mar 2006. Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments.

Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments, and links to the full deal in the deal listing at the rear of each report.

Table of Contents

Introduction

About Partneringdesk deals and alliances

Chapter 1: Deals in musculoskeletal diseases by company

Chapter 2: Deals in musculoskeletal diseases by development stage

Chapter 3: Deals in musculoskeletal diseases by type

Chapter 4: Deals in musculoskeletal diseases by industry sector

Chapter 5: Summary profiles for the most active companies in musculoskeletal diseases

Chapter 6: List of deals

Glossary

Back to Top